Advertisement
Canada markets open in 5 hours 39 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7273
    +0.0009 (+0.13%)
     

  • CRUDE OIL

    83.85
    +1.12 (+1.35%)
     

  • Bitcoin CAD

    88,799.07
    +4,523.83 (+5.37%)
     

  • CMC Crypto 200

    1,328.36
    +15.73 (+1.20%)
     

  • GOLD FUTURES

    2,403.30
    +5.30 (+0.22%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,421.00
    -126.25 (-0.72%)
     

  • VOLATILITY

    21.08
    +3.08 (+17.11%)
     

  • FTSE

    7,825.29
    -51.76 (-0.66%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, EAR, HYZN and SAVA

Kuznicki Law, PLLC
·2 min read

CEDARHURST, N.Y., Oct. 19, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.

Cassava Sciences, Inc. (SAVA)
Class Period: September 14, 2020 and August 27, 2021
Lead Plaintiff Motion Deadline: October 26, 2021
SECURITIES FRAUD
To learn more, visit https://kclasslaw.com/cases/securities/nasdaqcm-sava/

Hyzon Motors Inc. (NasdaqGS: HYZN, HYZNW) f/k/a Decarbonization Plus Acquisition Corporation (NasdaqGS: DCRB, DCRBU, DCRBW)
Class Period: February 9, 2021 and September 27, 2021
Lead Plaintiff Motion Deadline: November 29, 2021
SECURITIES FRAUD
To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-hyzn/

Eargo, Inc. (EAR)
Class Period: February 25, 2021 and September 22, 2021
Lead Plaintiff Motion Deadline: December 6, 2021
SECURITIES FRAUD
To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-ear/

ADVERTISEMENT

Bristol-Myers Squibb Company (BMY)
Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares of Celgene Corporation (CELG) pursuant to Bristol-Myers’ acquisition of Celgene on November 20, 2019
Lead Plaintiff Motion Deadline: December 6, 2021
MISLEADING PROSPECTUS
To learn more, visit https://kclasslaw.com/cases/securities/nyse-bmy/

Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above, by calling toll-free at 1-833-835-1495 or by email (dk@kclasslaw.com).

If you wish to serve as lead plaintiff with the goal of overseeing the litigation to obtain a fair and just resolution, you must petition the Court on or before the deadlines provided above.

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967
https://kclasslaw.com